A new tool for the paediatric HIV research: general data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe)
Ver/ Abrir
Registro completo
Mostrar el registro completo DCAutoría
José, María Isabel de; Jiménez de Ory, Santiago; Espiau, María; Fortuny, Claudia; Navarro, María Luisa; Soler-Palacín, Pere; Muñoz-Fernández, María Ángeles; Cabero Pérez, María Jesús
Fecha
2013Derechos
© 2013 de José et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Publicado en
BMC Infectious Diseases, 2013, 13, 2
Editorial
BioMed Central
Enlace a la publicación
Palabras clave
HIV paediatric cohort
Paediatric HIV infection
Spanish HIV HGM biobank
Resumen/Abstract
There are approximately from 1,100 to 1,200 HIV-infected children in a follow-up in Spain. In 2008 an open, multicentral, retrospective and prospective Cohort of the Spanish Paediatric HIV Network (CoRISpe) was founded. The CoRISpe is divided into the node 1 and node 2 representing geographically almost the whole territory of Spain. Since 2008 seventy-five hospitals have been participating in the CoRISpe. All the retrospective data of the HIV-infected children have been kept in the CoRISpe since 1995 and prospective data since 2008. In this article we are going to present the notion of CoRISpe, its role, the structure, how the CoRISpe works and the process how a child is transferred from Paediatric to Adults Units.
The main objective of the CoRISpe is to contribute to furthering scientific knowledge on paediatric HIV infection by providing demographic, sociopsychological, clinical and laboratory data from HIV-infected paediatric patients. Its aim is to enable high-quality research studies on HIV-infected children.
Colecciones a las que pertenece
- D06 Artículos [576]

Items relacionados
Mostrando ítems relacionados por título, autor, creador y tema.
-
Use of tocilizumab in kidney transplant recipients with COVID-1
Pérez Sáez, María J; Blasco, Miquel; Redondo Pachón, Dolores; Ventura Aguiar, Pedro; Bada Bosch, Teresa; Pérez Florez, Isabel; Melilli, Edoardo; Sánchez Cámara, Luis A; López Oliva, María O; Canal, Cristina; Shabaka, Amir; Garra Moncau, Nuria; Martín Moreno, Paloma L; López, Verónica; Hernández Gallego, Román; Siverio, Orlando; Galeano, Cristina; Espí Reig, Jordi; Cabezas, Carlos J; [et al.] (Wiley Periodicals Inc., 2020) -
Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study
Álvaro Gracia, Jose María; Sanchez-Piedra, Carlos; Manero, Javier; Ruiz-Lucea, María Ester; López-Vives, Laura; Bohorquez, Cristina; Martinez-Barrio, Julia; Bonilla, Gema; Vela, Paloma; García-Villanueva, María Jesús; Navío-Marco, María Teresa; Pavía, Marina; Galindo, María; Erausquin, Celia; González-Gay Mantecón, Miguel Ángel; Rua-Figueroa, Inigo; Pego-Reigosa, Jose M.; Castrejon, Isabel; Sanchez-Costa, Jesús T.; [et al.] (BMJ Publishing Group, 2021)
-
Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study
Peralta Fernández, Francisco Galo; Lamelo Otero, María; Álvarez García, Patricia; Velasco Arribas, María; Delgado-Iribarren, Alberto; Horcajada Gallego, Juan Pablo; Montero, María Milagro; Roiz Mesones, María Pía; Fariñas Álvarez, María del Carmen; Alonso Gutiérrez, Juan; Martínez Martínez, Luis
; Gutiérrez Macías, Alfonso; Álava Menica, José Ángel; Rodríguez Guardado, Azucena; Fleites, Ana; Navarro López, Vicente; Sirvent Quílez, Elia; Capdevila Morell, José Antonio (BioMed Central, 2012-10-05)